Osteopore International is a Singapore medical device company that design, develop, manufacture and distribute 3D printed bioresorbable implants.  The technology combines the science of Tissue Engineering and Regenerative Medicine with 3D printing to produce implantable devices with a biomimetic microarchitecture that enable the body to regenerate tissue such as bone.  We collaborate with clinicians and researchers internationally to develop products that address unmet clinical needs, reduce healthcare cost, improve patient outcomes and enhance lives.
 

The product is synthetic (not from animal or human source), and made from a polymer, polycaprolactone, that gradually resorb over 18-24 months. We have demonstrated tissue regeneration in our patients through clinical publications and more than 50 research publications.
 

The company was incorporated in late 2003, and have been in the implant business for 16 years. Our products are CE marked, US FDA 510(k) cleared, and have an implantation record of more than 20,000 implants globally.  

List of Patents:
• US6730252
• US7968026
• US8071007
• EP691726B1
• US9492279
• KR101726885B1
• US8702808
• SG195588A1